TIGIT and ulcerative colitis: In the chronic ulcerative colitis model, during the late inflammatory phase, DSS-treated mice may experience systemic T cell functional exhaustion or increased apoptosis, resulting in a widespread loss of TIGIT expression across subsets and impaired peripheral immune tolerance.